Enoxaparin Sodium
Pricing Report NDC 63323-569-99

Latest NADAC: $16.08114 per ML · Effective Aug 19, 2020 · Est. package price $128.65 (8 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Enoxaparin Sodium (NDC 63323-569-99) is $16.08114 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2020.

As a provided by Fresenius Kabi Usa, Llc, this medication is distributed in a 10 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$16.08114
Per ML

Effective Date
Aug 19, 2020
Billable Units
8 ML
Estimated Package Price
$128.65
Data Status
As of Sep 02, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
10 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2015, the NADAC wholesale price for (NDC ) has moved within a range of $11.40213 to $39.73690 per ML. Over this 5 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$11.4021 - $39.7369
Market Volatility
248.50% Variance
Latest Trend
4.53%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Nov 18, 2020 $11.40213 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 18, 2020 $14.71675 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $11.94327 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $14.24300 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $12.43240 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $15.96817 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $13.07370 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $16.08114 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $13.07370 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 19, 2020 $16.08114 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2020 $13.16617 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2020 $14.55174 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026